Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

FSD Pharma announces changes to its board of directors

FSD Pharma Inc (CSE:HUGE, NASDAQ:HUGE) has announced the appointments of Dr Lakshmi P. Kotra and Joseph L. Romano to its board of directors, and the resignation of Fernando Cugliari as a board member, effective November 25, 2022.

“On behalf of FSD, I would like to thank Mr. Cugliari for his contributions to the board. We wish him all the best in his future endeavours,” said Anthony Durkacz, FSD founder, interim CEO and executive co-chairman in a statement.

“We also welcome Dr. Kotra and Mr. Romano to the board of directors. Their combined wealth of knowledge and experience, we believe, will be valuable,” he added.

READ: FSD Pharma wins FDA and Health Canada approval for IND for Phase 2 Trial of FSD201 for treating inflammatory disorder

An academic entrepreneur, Dr Kotra has contributed to a number of important drug discovery and development projects, including metabolic disorders, neurodegenerative and immunological disorders, anti-HIV drugs, antibacterials, and antimalarials, FSD said.

He received his PhD in Pharmacy (Medicinal Chemistry) from the University of Georgia, and completed post-doctoral training at Wayne State University, before joining the Faculty of Pharmacy at the University of Toronto in 2000, and University Health Network in 2006, where he led a research group and drug discovery program with multiple portfolios.

Dr Kotra has authored/co-authored over 130 publications and delivered over 140 scientific talks internationally, and is the recipient of several awards for his accomplishments, including the Julia Levy Award in 2021 from the Society of Chemical Industry (SCI) Canada for his substantial contribution to the successful commercialization of innovation in Canada in the field of biomedical science and engineering.

In addition to Lucid Psycheceuticals Inc, he co-founded WinSanTor Biosciences, a San Diego, CA-based company developing treatments for peripheral neuropathies, and CannScience Innovations focused on medical cannabis and cannabinoids.

Joseph Romano is the founding member of Romano Law Firm. A graduate of Osgoode Hall Law School, Romano has dedicated his law career to helping victims of serious personal injury and motor vehicle accidents, FSD noted.

Contact the author at jon.hopkins@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK